Cargando…
Immunomagnetic isolation of circulating melanoma cells and detection of PD-L1 status
Personalised medicine targeted to specific biomarkers such as BRAF and c-Kit has radically improved the success of melanoma therapy. More recently, further advances have been made using therapies targeting the immune response. In particular, therapies targeting the PD-1/PD-L1 or CTLA-4 axes alone or...
Autores principales: | Po, Joseph W., Ma, Yafeng, Balakrishna, Bavanthi, Brungs, Daniel, Azimi, Farhad, de Souza, Paul, Becker, Therese M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368301/ https://www.ncbi.nlm.nih.gov/pubmed/30735560 http://dx.doi.org/10.1371/journal.pone.0211866 |
Ejemplares similares
-
Improved ovarian cancer EMT-CTC isolation by immunomagnetic targeting of
epithelial EpCAM and mesenchymal N-cadherin
por: Po, Joseph W, et al.
Publicado: (2018) -
Immunomagnetic isolation and in vitro expansion of human uveal melanoma cell lines
por: Cools-Lartigue, Jonathan J., et al.
Publicado: (2008) -
Evaluation of a multi-marker immunomagnetic enrichment assay for the quantification of circulating melanoma cells
por: Freeman, James B, et al.
Publicado: (2012) -
Immunomagnetic-Enriched Subpopulations of Melanoma Circulating Tumour Cells (CTCs) Exhibit Distinct Transcriptome Profiles
por: Aya-Bonilla, Carlos, et al.
Publicado: (2019) -
Choice of antibody is critical for specific and sensitive detection of androgen receptor splice variant-7 in circulating tumor cells
por: Khan, Tanzila, et al.
Publicado: (2022)